Sleep

In a future with more ‘mind reading,’ thanks to neurotech, we may need to rethink freedom of thought

Retrieved on: 
Tuesday, April 9, 2024

He warned that writing undermines memory – that it is nothing but a reminder of some previous thought.

Key Points: 
  • He warned that writing undermines memory – that it is nothing but a reminder of some previous thought.
  • Today, the U.S. is in the middle of a similar panic over TikTok, with critics worried about its impact on viewers’ freedom of thought.
  • Brain-computer interfaces, called BCIs, have rightfully prompted debate about the appropriate limits of technologies that interact with the nervous system.
  • But as my research on neurorights argues, protecting the mind isn’t nearly as easy as protecting bodies and property.

Thoughts vs. things

  • The body has clear boundaries, and things that cross it without permission are not allowed.
  • It is normally obvious when a person violates laws prohibiting assault or battery, for example.
  • The same is true about regulations that protect a person’s property.
  • Instead, a person’s thoughts are largely the product of other peoples’ thoughts and actions.
  • Everything from how a person perceives colors and shapes to our most basic beliefs are influenced by what others say and do.
  • If I’m not allowed to influence others’ thoughts, then I can never leave my house, because just by my doing so I’m causing people to think and act in certain ways.

Neurotech and control

  • People may not be able to completely control what gets into their heads, but they should have significant control over what goes out – and some people believe societies need “neurorights” regulations to ensure that.
  • Neurotech represents a new threat to our ability to control what thoughts people reveal to others.
  • There are ongoing efforts, for example, to develop wearable neurotech that would read and adjust the customer’s brainwaves to help them improve their mood or get better sleep.
  • For example, nations could prohibit companies that make commercial neurotech devices, like those meant to improve the wearer’s sleep from storing the brainwave data those devices collect.
  • Yet I would argue that it may not be necessary, or even feasible, to protect against neurotech putting information into our brains – though it is hard to predict what capabilities neurotech will have even a few years from now.
  • But one thing is certain: With or without neurotech, our control over our own minds is already less absolute than many of us like to think.


Parker Crutchfield does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Family caregivers can help shape the outcomes for their loved ones – an ICU nurse explains their vital role

Retrieved on: 
Tuesday, April 9, 2024

Marie landed in the intensive care unit where I am a bedside nurse because she was too agitated and needed more oxygen.

Key Points: 
  • Marie landed in the intensive care unit where I am a bedside nurse because she was too agitated and needed more oxygen.
  • As a seasoned bedside critical care nurse, I see firsthand the benefits that family caregivers bring to patient care in the hospital.
  • I also witness the emotional stress that caregivers experience when their loved one comes to the ICU.

Caregivers often battle anxiety and depression

  • From making medical decisions to advocating for their loved one, family caregivers have many important roles when their loved one is in the hospital.
  • However, caregivers carry heavy emotional burdens while supporting loved ones at the hospital.
  • Up to 70% of first-degree relatives of ICU survivors suffer from anxiety symptoms, more than a third suffer from depression, and many can experience symptoms of post-traumatic stress disorder, or PTSD.

Communication is critical

  • As you provide information about the patient at home, the medical team should be giving you updates about the patient’s condition in the hospital.
  • Knowing what to ask is essential to effective communication at the hospital.
  • Once familiar with your new environment, you may feel more at ease to truly be present for your loved one.
  • Every day, the interdisciplinary medical team sees each patient to discuss updates and treatment plans, and answers questions for the patient and their family.
  • Research has also shown that rounds relieve anxiety and stress among family caregivers due to the consistent daily communication and emotional support that they provide.

Nurses can be helpful

  • After clinical rounds, the interdisciplinary team of doctors and nurses establishes a daily plan of care for your loved one, which will be carried out by your bedside nurse.
  • The nurse will give the ordered medications, perform necessary clinical tasks and assess the patient for their response to the treatment.
  • Nurses are the most accessible resource you have when your loved one is in the hospital.

The importance of routines and familiarity

  • Preventing ICU delirium through reorientation and familiar faces can help prevent this serious complication and can even reduce their hospital stay.
  • Most families that come to the hospital describe the support they received from the medical team in a positive way.


Courtney Graetzer does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Orphan designation: Allogeneic cultured postnatal thymus-derived tissue Treatment of CHARGE syndrome, 26/02/2019 Positive

Retrieved on: 
Tuesday, April 9, 2024

Orphan designation: Allogeneic cultured postnatal thymus-derived tissue Treatment of CHARGE syndrome, 26/02/2019 Positive

Key Points: 


Orphan designation: Allogeneic cultured postnatal thymus-derived tissue Treatment of CHARGE syndrome, 26/02/2019 Positive

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

Retrieved on: 
Monday, March 25, 2024

NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced topline results from the CRESCENDO (Characterizing Patient Perspectives on Unmet Needs in Narcolepsy) survey of patients with narcolepsy type 1 (NT1, i.e., narcolepsy with cataplexy) receiving treatment, demonstrating high rates of persistent symptoms and significant patient burden, despite being on current treatments. CRESCENDO was conducted in partnership with Narcolepsy Network, a national non-profit patient support organization for people with narcolepsy, idiopathic hypersomnia, and related sleep disorders.

Key Points: 
  • CRESCENDO was conducted in partnership with Narcolepsy Network, a national non-profit patient support organization for people with narcolepsy, idiopathic hypersomnia, and related sleep disorders.
  • All patients taking part in the survey were currently undergoing treatment for NT1.
  • The most common treatments were wake promoting agents (about 53% of surveyed patients), oxybates (47%), and stimulants (42%).
  • Axsome plans to present the detailed results of the CRESCENDO survey at upcoming scientific meetings.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Vanda Pharmaceutical Inc. - VNDA

Retrieved on: 
Saturday, March 23, 2024

NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceutical Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA).

Key Points: 
  • NEW YORK, March 23, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Vanda Pharmaceutical Inc. (“Vanda” or the “Company”) (NASDAQ: VNDA).
  • The investigation concerns whether Vanda and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

University of South Florida research funding reaches record high of $692 million

Retrieved on: 
Wednesday, March 20, 2024

“The University of South Florida's record-breaking success in research funding is a reflection of our commitment to advancing new knowledge, fostering innovation and making a positive impact on society," USF President Rhea Law said.

Key Points: 
  • “The University of South Florida's record-breaking success in research funding is a reflection of our commitment to advancing new knowledge, fostering innovation and making a positive impact on society," USF President Rhea Law said.
  • "The dedicated work of our world-class faculty, talented research staff and collaborative partners continues to lift USF’s research enterprise to new heights."
  • USF’s funding from private partnerships grew by 11% to $218 million, while funding from state and local sources nearly doubled to $82 million.
  • “This substantial increase in research enterprise funding reflects USF’s stature as a top public research university,” said Sylvia Wilson Thomas, USF vice president for research and innovation.

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates

Retrieved on: 
Tuesday, March 19, 2024

Notably, she has vastly increased interest in social communication and activities at week 35 compared to earlier post-treatment assessments.

Key Points: 
  • Notably, she has vastly increased interest in social communication and activities at week 35 compared to earlier post-treatment assessments.
  • Dr. Schultz is a board-certified, licensed pediatric neurologist experienced in treating patients with Rett syndrome and leading gene therapy clinical trials.
  • She brings more than 17 years of clinical experience and will lead the Company’s clinical development, clinical operations, medical affairs and safety activities.
  • ET to review its financial and operating results and to provide corporate and clinical updates.

Rob Sutton Joins Wondr Health as New Chief Financial Officer

Retrieved on: 
Tuesday, March 19, 2024

Dallas, TX, March 19, 2024 (GLOBE NEWSWIRE) -- DALLAS, TX (March 19, 2024) – Wondr Health , the proven leader in metabolic, emotional, and physical health transformation, today announced that it appointed Rob Sutton, CPA, as Executive Vice President and Chief Financial Officer.

Key Points: 
  • Dallas, TX, March 19, 2024 (GLOBE NEWSWIRE) -- DALLAS, TX (March 19, 2024) – Wondr Health , the proven leader in metabolic, emotional, and physical health transformation, today announced that it appointed Rob Sutton, CPA, as Executive Vice President and Chief Financial Officer.
  • Sutton joins Wondr Health at an exciting time of growth and market expansion for the organization after years of proven service in the digital health and benefits space.
  • “Wondr Health is in a rapid growth phase, and Rob’s extensive executive-level financial expertise as well as his experience working with private equity companies will be invaluable to the organization,” said Scott Paddock, Chief Executive Officer, Wondr Health.
  • Prior to joining Wondr Health, Sutton was Executive Vice President and Chief Financial Officer for Ventra Health.

Dream Valley x Outlast Technologies Launch Cooling Comforter with NASA-grade Aerospace Temperature Regulating Technology

Retrieved on: 
Friday, March 15, 2024

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Dream Valley®, a leading innovator in sleep technology, has introduced its Dream Valley Cooling Comforter featuring the Outlast® temperature-regulating filling on World Sleep Day.

Key Points: 
  • NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Dream Valley®, a leading innovator in sleep technology, has introduced its Dream Valley Cooling Comforter featuring the Outlast® temperature-regulating filling on World Sleep Day.
  • Aimed to extend deep sleep every night, the Dream Valley Cooling Comforter incorporates the Outlast phase-changing material (PCM) to offer soothing coolness for hot sleepers by proactively regulating an optimal sleeping temperature and alleviating night sweats.
  • "Dream Valley helps people reach healthier, deeper, high-quality sleep," said Shadow Wang, CEO of Dream Valley.
  • At the core of the Dream Valley Cooling Comforter is the Outlast temperature-regulating filling, which reduces sweating and extends deep sleep for hot sleepers.

ResMed's 2024 Global Sleep Survey Uncovers a World in Sleep Crisis

Retrieved on: 
Friday, March 15, 2024

More than one-third of respondents are now actively tracking their sleep patterns, and many are adjusting bedtime routines in an effort to improve sleep quality.

Key Points: 
  • More than one-third of respondents are now actively tracking their sleep patterns, and many are adjusting bedtime routines in an effort to improve sleep quality.
  • SAN DIEGO, March 15, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD), the global leader in digital health and cloud-connected medical devices that transform care for people with sleep apnea, COPD, and other chronic diseases, today announced the results of its 2024 Global Sleep Survey in conjunction with World Sleep Day (March 15), shedding light on the critical sleep challenges faced by people around the world.
  • To learn more about ResMed’s 2024 Global Sleep Survey or for help identifying if you have symptoms that could indicate poor sleep health, visit https://www.resmed.com/sleepassessment .
  • The 2024 ResMed Global Sleep Survey included a total of 36,000 respondents across 17 markets including Australia, Brazil, China, France, Germany, Hong Kong, India, Ireland, Japan, Korea, Mexico, New Zealand, Singapore, Taiwan, Thailand, UK and USA, between December 2023 and January 2024.